DB
ANIP icon

Danske Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Danske Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$15.8K – 1196
2025
Q4 		$15.8K Sell
200
-9,236
-98% -$800K ﹤0.01% 1246
2025
Q3 		$864K Sell
9,436
-7,172
-43% -$585K ﹤0.01% 708
2025
Q2 		$1.08M Sell
16,608
-11,133
-40% -$725K ﹤0.01% 711
2025
Q1 		$1.86M Sell
27,741
-632
-2% -$37.7K 0.01% 688
2024
Q4 		$1.57M Buy
28,373
+12,935
+84% +$743K ﹤0.01% 757
2024
Q3 		$921K Buy
15,438
+13,338
+635% +$814K ﹤0.01% 823
2024
Q2 		$134K Buy
+2,100
New +$136K ﹤0.01% 932

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Danske Bank's ANIP Position: Q1 2026 in Review

Danske Bank sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 200 shares — an estimated $15.8K sold.

Danske Bank first reported a position in ANIP in Q2 2024 and held it in 7 quarters. The position peaked at $1.86M in Q1 2025. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Danske Bank reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 200 ANI Pharmaceuticals shares in Q1 2026, an estimated $15.8K.
  • Danske Bank first reported a position in ANI Pharmaceuticals in Q2 2024 and held it in 7 quarters.
  • Danske Bank's ANI Pharmaceuticals position peaked at $1.86M in Q1 2025.
  • 281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.